| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068094 Physiologically active exract |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068066 Method for the treatment and prevention of dental caries |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020068055 Preventive and therapeutic antiviral drug for aids, hepatitis B, hepatitis C and influenza |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | DE10055789A1 DNA-Sequenz und Microcin aus Escherichia coli StammDSM 6601 DNA sequence and Microcin from Escherichia coli 6601 StammDSM |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431839A1 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430292A1 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 06/06/2002 | CA2430239A1 A method of treating cancer |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| 06/05/2002 | EP1211259A1 Antibiotic caprazamycins and process for producing the same |
| 06/05/2002 | EP1211254A1 Process for the preparation of benzoxazine derivatives and intermediates therefor |
| 06/05/2002 | EP1211240A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 06/05/2002 | EP1210947A1 Ophthalmic ointments for treating infective eye diseases |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE |
| 06/05/2002 | EP1210354A1 Prodrugs for liver specific drug delivery |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210347A1 Carbocyclic nucleosides and process for obtaining such |
| 06/05/2002 | EP1210336A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210330A1 Antibacterial agents |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210182A1 Permeabilizing biofilms |
| 06/05/2002 | EP1210132A1 Herb medicine composition to be contained in sanitary materials for infants |
| 06/05/2002 | EP1210131A1 Herb medicine composition to be spread on sanitary napkin for female |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210116A2 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 06/05/2002 | EP1210114A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 06/05/2002 | EP1210113A2 Combined vaccine compositions |
| 06/05/2002 | EP1210112A2 Vaccine against hbv and hpv |
| 06/05/2002 | EP1210111A1 Gamma-herpesvirus dna and methods of use |
| 06/05/2002 | EP1210110A1 Prion protein binding proteins and uses thereof |
| 06/05/2002 | EP1210104A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210088A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 06/05/2002 | EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP0951474B1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0951473B1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same |
| 06/05/2002 | EP0948527B1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0930888B1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0894008B1 Method of producing immunogenic products and vaccines |
| 06/05/2002 | EP0884997B1 Compositions containing an antifungal and a sulfur compound |
| 06/05/2002 | EP0876336B1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 06/05/2002 | EP0874853B1 Process for preparation of cefdinir |
| 06/05/2002 | EP0809506B1 Antimicrobial composition composed of controlled release glasses |
| 06/05/2002 | EP0790057B1 Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
| 06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
| 06/05/2002 | EP0755386B1 Benzamide derivative, compositions containing said derivative and use thereof |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352649A Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus |